GI
AVXL icon

GAMMA Investing’s Anavex Life Sciences AVXL Stock Holding History

GAMMA Investing’s Portfolio AVXL Stock Details AVXL Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$233 Sell
90
-290
-76% -$858 ﹤0.01% 4075
2026
Q1 		$1.17K Sell
380
-64
-14% -$277 ﹤0.01% 3807
2025
Q4 		$1.58K Sell
444
-1,011
-69% -$6.19K ﹤0.01% 3671
2025
Q3 		$12.9K Buy
1,455
+144
+11% +$1.46K ﹤0.01% 2746
2025
Q2 		$12.1K Sell
1,311
-1,490
-53% -$12.7K ﹤0.01% 2714
2025
Q1 		$24K Buy
2,801
+1,562
+126% +$14.8K ﹤0.01% 2275
2024
Q4 		$13.3K Buy
1,239
+631
+104% +$4.85K ﹤0.01% 2465
2024
Q3 		$3.45K Buy
608
+470
+341% +$2.71K ﹤0.01% 2884
2024
Q2 		$582 Sell
138
-64
-32% -$259 ﹤0.01% 3180
2024
Q1 		$1.03K Sell
202
-1,155
-85% -$6.5K ﹤0.01% 2934
2023
Q4 		$8.1K Buy
+1,357
New +$9.34K ﹤0.01% 2019

Other funds holding AVXL

PAM
PVG Asset Management Golden, Colorado $173M AUM 64.51% 1-Year Est. Return
AC
Apella Capital West Hartford, Connecticut $7.08B AUM 17.38% 1-Year Est. Return
SSWM
Sheets Smith Wealth Management Winston-Salem, North Carolina $1B AUM 29.77% 1-Year Est. Return
1WA
180 Wealth Advisors Federal Way, Washington $997M AUM 47.84% 1-Year Est. Return
LA
LexAurum Advisors Overland Park, Kansas $866M AUM
AHL
Abel Hall LLC Baton Rouge, Louisiana $579M AUM 54.21% 1-Year Est. Return
FVWA
Foster Victor Wealth Advisors Greenville, South Carolina $1.9B AUM 24.46% 1-Year Est. Return
FFM
Forum Financial Management Lombard, Illinois $7.79B AUM 20.38% 1-Year Est. Return
Wealth Enhancement Advisory Services
Wealth Enhancement Advisory Services Plymouth, Minnesota $59.8B AUM 29.42% 1-Year Est. Return
PFSRSONJ
Police & Firemen's Retirement System of New Jersey Trenton, New Jersey $13.3B AUM 45.46% 1-Year Est. Return

GAMMA Investing's AVXL Position: Q2 2026 in Review

GAMMA Investing reduced its Anavex Life Sciences (AVXL) stake by 76% in Q2 2026, selling an estimated $858 and leaving 90 shares worth $233. The position accounts for ﹤0.01% of the portfolio, ranked #4075.

GAMMA Investing first reported a position in AVXL in Q4 2023 and has held it in 11 quarters since. The position peaked at $24K in Q1 2025. 29 funds tracked by Wall St. Rank hold AVXL as of Q2 2026.

  • GAMMA Investing held 90 shares of Anavex Life Sciences worth $233 as of Q2 2026.
  • GAMMA Investing sold 290 Anavex Life Sciences shares in Q2 2026, an estimated $858.
  • Anavex Life Sciences made up ﹤0.01% of GAMMA Investing's portfolio in Q2 2026, its #4075 holding.
  • GAMMA Investing first reported a position in Anavex Life Sciences in Q4 2023 and has held it in 11 quarters since.
  • GAMMA Investing's Anavex Life Sciences position peaked at $24K in Q1 2025.
  • 29 funds tracked by Wall St. Rank held Anavex Life Sciences as of Q2 2026.

Based on GAMMA Investing's 13F filing for Q2 2026, filed 7 Jul 2026.